DeviceClearance

Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)— 510(k) K233242

Substantially Equivalent

Siemens Healthcare Diagnostics, Inc.

FDA 510(k) clearance K233242 for Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2), Substantially Equivalent on 2024-01-18. Applicant: Siemens Healthcare Diagnostics, Inc..

Clearance details

Applicant
Siemens Healthcare Diagnostics, Inc.
Product code
Code NQD
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Newark, DE, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.